RJ-28

N/A

Report date: 2025/01/26 16:23:18
NME

Base Information

Drug NameRJ-28
Drug Alias NameRPS6K1 inhibitor (Xavier University of Louisiana)RJ-28
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of Action70-kDa ribosomal protein S6 kinases inhibitors
Targets70-kDa ribosomal protein S6 kinases
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesXavier University Of Louisiana.
China Registration ClassN/A

Develop Information

Active CompaniesXavier University Of Louisiana.
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A